| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/23/2004 | WO2004081050A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | WO2004081040A2 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |
| 09/23/2004 | WO2004081030A2 Peptides selectively lethal to malignant and transformed mammalian cells |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080406A2 Therapeutic compositions |
| 09/23/2004 | WO2004080394A2 Stat3 antagonists and their use as vaccines against cancer |
| 09/23/2004 | WO2004080273A2 Compositions and methods for diagnosing and treating prostate cancer |
| 09/23/2004 | WO2004072293A3 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor |
| 09/23/2004 | WO2004055166A3 Multi-antigenic alphavirus replicon particles and methods |
| 09/23/2004 | WO2004050870A3 Genetic switches for the detection of fusion proteins |
| 09/23/2004 | WO2004049964A3 Drug to be introduced tooth or periodontal tissue and apparatus for introducing drug to tooth or periodontal tissue |
| 09/23/2004 | WO2004035082A3 Proteins involved in the regulation of energy homeostasis |
| 09/23/2004 | WO2004030634A3 Therapeutic compositions |
| 09/23/2004 | WO2003103601A3 Methods of diagnosing & treating diabetes and insulin resistance |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003068809A8 An herpes simplex virus complex |
| 09/23/2004 | WO2003061681A3 Proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/23/2004 | US20040186423 Systems and methods for treating ischemia |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186175 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/23/2004 | US20040186068 Introduction of an alteration to the polypeptide to form an altered polypeptide; the assembly of a multiplicity of transcriptional regulatory factors on the altered polypeptide to form a controllable platform; and the specific targeting of the controllable platform to a plurality of promoters |
| 09/23/2004 | US20040186067 Vectors and methods for immunization or therapeutic protocols |
| 09/23/2004 | US20040186048 Gene regulation therapy involving ferritin |
| 09/23/2004 | US20040185563 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185508 Methods and reagents for modulating cholesterol levels |
| 09/23/2004 | US20040185468 Promoter variants of the alpha-7 nicotinic acetylcholine receptor |
| 09/23/2004 | US20040185113 Sparingly water-soluble calcium-containing inorganic microparticles and a drug or biodrug encapsulated therein; made by adding a calcium compound to a solution of a carbonate, phosphate, oxalate or urate and the drug to form the calcium salt of the carbonate, phosphate, oxalate or urate |
| 09/23/2004 | US20040185104 Biodegradable and water soluble polyesterether block polymers possessing reverse thermal gelation properties, used for drug delivery of genes, peptides, anticancer or antiproliferative agents |
| 09/23/2004 | US20040185083 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 09/23/2004 | US20040185059 Biotin-binding receptor molecules |
| 09/23/2004 | US20040185058 Immunogenic polypeptides physically linked; anticarcinogenic, antitumor, antiallergen, and viricidal agents; autoimmune diseases; systemic or mucosal vaccines; genetic engineering |
| 09/23/2004 | US20040185030 Methods and materials for treating inflammatory diseases |
| 09/23/2004 | DE10310196A1 Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose Use of a tricyclic antidepressant to promote endocytosis |
| 09/23/2004 | CA2557737A1 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications |
| 09/23/2004 | CA2518912A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518898A1 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518787A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | CA2518552A1 Novel compositions and methods for the treatment of immune related disease |
| 09/23/2004 | CA2518549A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | CA2518475A1 Irna agents comprising asymmetrical modifications |
| 09/22/2004 | EP1459756A1 REMOVAL PROMOTERS AND INHIBITOR FOR APOPTOSIS CELLS i IN VIVO /i |
| 09/22/2004 | EP1459754A1 Preventives/remedies for cancer |
| 09/22/2004 | EP1459070A2 Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers |
| 09/22/2004 | EP1458879A2 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 09/22/2004 | EP1458870A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458864A1 Tgf-beta-specific covalently closed antisense molecule |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |
| 09/22/2004 | EP1458862A2 Suppression of polymeric alleles |
| 09/22/2004 | EP1458858A2 Histone h3 methyltransferase polypeptide |
| 09/22/2004 | EP1458755A2 Novel g-protein coupled receptors and dna sequences thereof |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458749A2 Bone polypeptide-1 |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458403A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/22/2004 | EP1458362A2 Pharmaceutical compositions in particulate form |
| 09/22/2004 | EP1458240A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 09/22/2004 | EP1223916B1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 09/22/2004 | EP1001750B1 Stable particulate complexes with neutral or negative globale charge of lamellar structure |
| 09/22/2004 | EP0975774B1 Bacterial plasmids |
| 09/22/2004 | EP0914442B1 Avian polynucleotide vaccine formula |
| 09/22/2004 | EP0771355B1 A method for large scale plasmid purification |
| 09/22/2004 | EP0706575B1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 09/22/2004 | EP0682708B1 Antiviral composition of viral protein trans-dominant variants |
| 09/22/2004 | CN1531653A Method for identification of proteins from intracellular bacteria |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531596A Methods for stable transduction of cells with viral vectors |
| 09/22/2004 | CN1531591A Method for introducing nucleic acids and other biologially active molecules into nucleus of higher exkaryotic cells by means of electrical current |
| 09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
| 09/22/2004 | CN1531440A Pharmaceutical composition for preventing or treating TH1 and TH2 cell related diseases by modulating TH/TH2 ratio |
| 09/22/2004 | CN1531438A Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 09/22/2004 | CN1531422A Gene delivery formulations and methods for treatment of ischemic conditions |
| 09/22/2004 | CN1530444A Gene related to blood sugar regulation, protein product and use thereof |
| 09/22/2004 | CN1167795C Novel peptide, novel DNA and novel antibody |
| 09/22/2004 | CN1167793C Polypeptides encoded by human lipase-like gene, compositions and methods |
| 09/22/2004 | CN1167468C Preparation of transgenic compound particles of alkylated chitosan |
| 09/22/2004 | CN1167465C Fusion anticaries DNA vaccine and its preparation |
| 09/22/2004 | CN1167461C Carbon dioxide enhancement of inhalation therapy |
| 09/21/2004 | US6794500 RNA-binding protein |
| 09/21/2004 | US6794376 Delivering a therapeutic agent to said tissue; delivering a permeabilizer to the tissue; and elevating the temperature of the tissue to above normal body temperature. |
| 09/21/2004 | US6794367 Solid preparations for oral administration of drugs relating to genes |
| 09/21/2004 | US6794363 Isolated amyloid inhibitor protein (APIP) and compositions thereof |
| 09/21/2004 | US6794188 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |
| 09/21/2004 | US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/21/2004 | US6794144 Using random manipulation of the non-conserved region of sh3 rt-loop; nef proteins; for research, diagnostics, therapy and drug discovery |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | US6793918 Genetic engineering; insertion of adenovirus vectors into cells |
| 09/21/2004 | CA2195668C Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 09/16/2004 | WO2004079372A1 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-trp |
| 09/16/2004 | WO2004078986A1 Infectious flavivirus pseudo-particles containing functional prm and/or e proteins |
| 09/16/2004 | WO2004078971A1 Method of demethylating target methylated region of genomic dna |
| 09/16/2004 | WO2004078950A2 METHODS AND COMPOSITIONS FOR SELECTIVE RNAi MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMAL CELLS |
| 09/16/2004 | WO2004078942A2 Endothelial cell specific antibodies and uses thereof |
| 09/16/2004 | WO2004078940A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1 |